Illumina Defends Validity Of DNA Sequencing Patents At Trial
A California federal jury heard testimony Friday from gene sequencing company Illumina's expert witness that 10 judges who previously upheld Illumina's patents behind its next-generation technology "got it right," one day...To view the full article, register now.
Already a subscriber? Click here to view full article